Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series.

Tsubota S, Kaneko GO, Igarashi D, Takahashi T, Baba Y, Shirotake S.

Open source

DOI
10.21873/invivo.14528
Published
2026-11-01
Container
In Vivo
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21873/invivo.14528,
  title = {Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series.},
  author = {Tsubota S and  Kaneko GO and  Igarashi D and  Takahashi T and  Baba Y and  Shirotake S.},
  year = {2026},
  journal = {In Vivo},
  doi = {10.21873/invivo.14528},
  url = {https://doi.org/10.21873/invivo.14528}
}

RIS

TY  - JOUR
TI  - Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series.
AU  - Tsubota S
AU  -  Kaneko GO
AU  -  Igarashi D
AU  -  Takahashi T
AU  -  Baba Y
AU  -  Shirotake S.
PY  - 2026
JO  - In Vivo
DO  - 10.21873/invivo.14528
UR  - https://doi.org/10.21873/invivo.14528
ER  - 

APA

S, T., GO, K., D, I., T, T., Y, B., & S., S. (2026). Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series.. In Vivo. https://doi.org/10.21873/invivo.14528

Source records